Deutsche Bank calls Eli Lilly a ‘high growth unicorn’ in upgrade to Buy

Eli Lilly and Company Research Laboratories. Lilly makes Medicines and Pharmaceuticals.

jetcityimage/iStock Editorial via Getty Images

Eli Lilly (NYSE:LLY) was in the spotlight on Monday after Deutsche Bank raised its recommendation on the stock to Buy from Hold, calling the drugmaker a “high growth unicorn” following its Q2 beat-and-raise results.

The Indiana-based drugmaker raised its full-year

Leave a Reply

Your email address will not be published. Required fields are marked *